Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program

SIMPLE SUMMARY: Women with a BRCA1 or BRCA2 gene mutation have up to an 80% lifetime risk of breast cancer unless their breasts are surgically removed, but many decline or defer surgery and choose screening, hoping that if cancer occurs, it will be detected at a curable stage. In this study 489 wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Warner, Ellen, Zhu, Siqi, Plewes, Donald B., Hill, Kimberley, Ramsay, Elizabeth A., Causer, Petrina A., Seely, Jean, Jong, Roberta A., Lenkov, Pamela, Elser, Christine, Crystal, Pavel, Yaffe, Martin J., Giannakeas, Vasily, Sun, Ping, Narod, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700272/
https://www.ncbi.nlm.nih.gov/pubmed/33238387
http://dx.doi.org/10.3390/cancers12113479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700272/
https://www.ncbi.nlm.nih.gov/pubmed/33238387
http://dx.doi.org/10.3390/cancers12113479

Ejemplares similares